To determine whether this low Sox2/Oct4 expression is a common phenomenon in AML, we examined the expression of Sox2/Oct4 in a panel of nine bone marrow aspirates from patients with diagnosed AML. This evidence concerns the gene POU5F1 and acute myeloid leukemia.